about
MINERVA: a multi-modality plugin-based radiation therapy treatment planning system.Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging.Quality assurance for nonradiographic radiotherapy localization and positioning systems: report of Task Group 147.Long term OSLD reader stability in the ACDS level one auditHuman in vivo dose-response to controlled, low-dose low linear energy transfer ionizing radiation exposure.The Australian Clinical Dosimetry Service: a commentary on the first 18 monthsSU-E-T-164: Clinical Implementation of ASi EPID Panels for QA of IMRT/VMAT Plans.Dosimetry of ionising radiation in modern radiation oncology.Virtual EPID standard phantom audit (VESPA) for remote IMRT and VMAT credentialing.Image guided radiation therapy (IGRT) technologies for radiation therapy localization and delivery.Short communication: nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells.Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy.Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.Comparison of peripheral dose from image-guided radiation therapy (IGRT) using kV cone beam CT to intensity-modulated radiation therapy (IMRT).A 2D ion chamber array audit of wedged and asymmetric fields in an inhomogeneous lung phantom.Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.Dosimetry for quantitative analysis of the effects of low-dose ionizing radiation in radiation therapy patients.Film dosimetry in the peripheral region using multiple sensitometric curves.A virtual dosimetry audit - Towards transferability of gamma index analysis between clinical trial QA groups.Technical note: TROG 15.01 SPARK trial multi-institutional imaging dose measurement.A novel and independent method for time-resolved gantry angle quality assurance for VMAT.Commissioning of a PTW 34070 large-area plane-parallel ionization chamber for small field megavoltage photon dosimetry.XINPUT: a program to edit "DOSRZ" input files.Spatial response of synthetic microDiamond and diode detectors measured with kilovoltage synchrotron radiation.National dosimetric audit network finds discrepancies in AAA lung inhomogeneity corrections.Remote auditing of radiotherapy facilities using optically stimulated luminescence dosimeters.Comparison between the TRS-398 code of practice and the TG-51 dosimetry protocol for flattening filter free beams.High spatial resolution dosimetric response maps for radiotherapy ionization chambers measured using kilovoltage synchrotron radiation.Angular dependence of the response of the nanoDot OSLD system for measurements at depth in clinical megavoltage beams.Excessive applicator radiation leakage for a common therapeutic kilovoltage systemEffects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7)Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cellsOn using 3D γ-analysis for IMRT and VMAT pretreatment plan QAThe effect of very small air gaps on small field dosimetryImpact of magnetic fields on dose measurement with small ion chambers illustrated in high-resolution response maps
P50
Q33239408-8157236B-86E3-4338-8CA8-BB4D009E0AC9Q34117105-61138443-880B-4E25-95F2-7AB4D7E3E058Q34223829-6EF51E32-4416-478F-A281-60E875CC2609Q35652006-2C99BD01-340C-480A-96DA-9CC7689A0511Q36508213-ABAA3632-D2A2-40F8-96D5-CC247A2F3B67Q36582096-39F3B9B1-368E-4E81-9B75-C33D113D2FB0Q38778292-D9330653-80E5-497E-9517-550F8BE7E4A1Q38847695-FD389D75-C4A0-4B45-8DB8-5B8685AD1626Q38935855-49FDCA98-18A8-49BA-AB6B-ED083D708F88Q39420955-B0338A35-095B-4A99-8330-B70DE29E04A7Q39985646-AAEC528D-D32C-4CC1-A9B6-F313AFB406D8Q40102027-27738A4A-6DBB-4352-8336-CBF0881616AEQ42651990-9EB37DDE-BEA8-4A73-8474-DD959D65B97FQ44646295-88AB7CE7-7B30-4556-8738-8FC72FD8F397Q44695124-6F37A7E8-D004-4A2F-A025-D9FB0854F012Q46197226-4E46C47A-8722-4B9E-BE7F-5F814D253DCAQ46221883-B0FA03C5-21E3-440D-A449-1FF3F45390E3Q46272144-A8A5879A-6F08-487A-97B1-8853AAA80758Q47662085-E0973878-A2D0-436D-B097-288D1285B037Q47742446-C2B0150E-B311-450A-8823-6B831C9B5726Q47768221-14F46BE0-F23E-45C4-9994-5DE3F9044257Q47856670-FC04C5BE-FE2B-4F9D-83F9-95EB24C59D7EQ48628302-94B0BFAF-8D1F-4090-837C-739D542D3AFDQ49819398-04729EEC-632E-4D7A-ABFB-00471AE5572CQ50923485-6507A618-DE79-4A5C-8877-FD2FF849CF50Q51105206-DD16A87A-F587-40AD-9304-B29103775756Q51273047-6EAA59C9-7504-4B79-99E5-7DA58D8037C2Q51669009-D9E04470-58A6-4984-9465-3A12BDC74F17Q53538610-3815E31D-D27E-41B3-AB14-B3D3E9F6CC2EQ57784898-B5A4F971-6214-46B0-848B-06E3C0DADDF6Q74484548-80CABBF7-43B7-429E-A165-27CD4958DB2BQ79936631-495CC5DE-6F50-48E2-9D05-021D29F13639Q84512667-50F4F731-88AD-4B8B-905F-228DD9AC4018Q87417528-D96014DD-BE0E-4A68-94C9-74C930E30359Q92007934-26830661-50C7-417C-9AA5-5A11F376A69B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joerg Lehmann
@ast
Joerg Lehmann
@en
Joerg Lehmann
@es
Joerg Lehmann
@nl
type
label
Joerg Lehmann
@ast
Joerg Lehmann
@en
Joerg Lehmann
@es
Joerg Lehmann
@nl
prefLabel
Joerg Lehmann
@ast
Joerg Lehmann
@en
Joerg Lehmann
@es
Joerg Lehmann
@nl
P106
P1153
37018436000
P31
P496
0000-0001-7667-3090